Provided by Tiger Trade Technology Pte. Ltd.

SHINEWAY PHARM

8.520
+0.1101.31%
Volume:1.77M
Turnover:15.02M
Market Cap:7.05B
PE:5.81
High:8.600
Open:8.415
Low:8.340
Close:8.410
52wk High:9.945
52wk Low:7.210
Shares:827.00M
HK Float Shares:827.00M
Volume Ratio:0.97
T/O Rate:0.21%
Dividend:0.61
Dividend Rate:7.12%
EPS(LYR):1.468
ROE:10.05%
ROA:3.90%
PB:0.74
PE(LYR):5.81
PS:2.27

Loading ...

Shineway Pharma Surges Over 5% in Afternoon Trade as H1 Revenue Drops 28.5% to RMB 1.181 Billion

Deep News
·
Aug 27

China Shineway Pharmaceutical Declares RMB 0.80 Second Interim Dividend for FY 2026

Bulletin Express
·
Aug 27

Shineway Pharma Posts 23.7% Profit Decline in Interim Results

Stock News
·
Aug 27

China Shineway Pharmaceutical - Profit for H1 Rmb469.2 Mln

THOMSON REUTERS
·
Aug 27

China Shineway Pharmaceutical - Declared 2026 Second Interim Dividend of RMB80 Cents Per Share

THOMSON REUTERS
·
Aug 27

China Shineway FY26 H1 Profit Drops 23.7% to RMB 469.16 Million; Revenue Falls 28.5% to RMB 1.18 Billion

Reuters
·
Aug 27

China Shineway Pharma Declares RMB 0.8 Fy2026 Second Interim Dividend

Reuters
·
Aug 27

China Shineway Pharma Schedules Board Meeting on Interim Results, Dividend Decision

Reuters
·
Aug 17

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Simply Wall St.
·
Jul 17

Shineway Pharma AGM Clears All Motions; Confirms Board Line-up and 20% Share Issuance Mandate

Bulletin Express
·
May 28

SHINEWAY PHARM Reports 18% Revenue Decline in Q1 2026

Stock News
·
May 07

China Shineway Pharmaceutical - Q1 Turnover RMB624 Mln

THOMSON REUTERS
·
May 07

China Shineway Q1 turnover falls 18% to RMB 624 million

Reuters
·
May 07

Tianjin Binhai Teda Logistics unit Yuan Da Logistics pays RMB 7.16 million in back taxes

Reuters
·
Apr 30

China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report

Bulletin Express
·
Apr 23

Shineway Pharmaceutical’s 2025 ESG Report: Higher Carbon Footprint Offset by Waste-Reduction Gains and Strong Social Commitments

Bulletin Express
·
Apr 23

Shineway Pharmaceutical to Seek Shareholders’ Approval on Financials, Board Re-elections and 20% Issuance Mandate at 28 May 2026 AGM

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 23

SHINEWAY PHARM 2025年业绩:收入承压净利逆势增长,聚焦创新中药与成本管控

Bulletin Express
·
Apr 23